Susan Ehret

Retired VP of Strategic Planning & Insights @danafarber, passionate about healthcare communications. Avid cyclist & outdoor enthusiast. Views are my own.

[Andy Lane @lane_andy]

Pivekimab sunirine (PVEK) approved today for #BPDCN. This is the second drug specifically approved for this rare leukemia. Great news for patients. Happy to have contributed to development of this agent over the past years with many great collaborators.
https://t.co/gl7StWi2Xk

[Dana-Farber News @DanaFarberNews]

.@DanaFarber’s Dr. Paul Richardson presents results from the SUCCESSOR-2 study showing the oral drug mezigdomide markedly improved PFS in patients w/relapsed or refractory multiple myeloma. Results support this potent & novel therapy as a possible new standard of care for RRMM. #ASCO26

➡️https://t.co/hiiTW74yNp

[Dana-Farber News @DanaFarberNews]

Congratulations to the 10 @DanaFarber nurses whose patients, their families, and colleagues nominated them for the @BostonGlobe’s Salute to Nurses for moments of connection that shaped their experiences and outcomes in ways that transcend clinical care.

Read more: https://t.co/Rjslhfq12E

[Susan Ehret @SusanDFCI]

❤️ Every new day arrives with fresh perspective, renewed energy, & opportunities we couldn’t see yesterday!

[Dana-Farber News @DanaFarberNews]

In the @BostonGlobe’s Salute to Nurses, @DanaFarber nurse Brianna O’Brien, BSN, RN, OCN, notes how AI cannot replace the importance of human connection. “When patients trust their nurses, they might admit they don’t understand their medication schedule, reveal a new symptom, or ask hard questions. And that honesty can drive better outcomes," O'Brien said.

➡️https://t.co/AbaHqjafxZ

[Dana-Farber's Young-Onset Colorectal Cancer Center @DFarberYoungCRC]

On @boston25 news this morning, @KimmieNgMD discussed the rise in rectal cancer in young adults along with the signs and symptoms to look out for and different ways to screen for colorectal cancer. #ColorectalCancer #Boston25
https://t.co/OoDaAzsclC

[Dana-Farber @DanaFarber]

This weekend, our researchers will present more than 50 studies at the American Association for Cancer Research (AACR) Annual Meeting in San Diego. Learn more about our #AACR26 highlights here: https://t.co/AJfQLHzOU3

[Dana-Farber @DanaFarber]

Ursula A. Matulonis, MD, of @DFCIGynOnc brings expert insights into the most recent breakthroughs, evolving standards, and emerging therapies across gynecologic cancers in her series with @OncLive, From Discovery to Delivery: Charting Progress in Gynecologic Oncology. Watch here: https://t.co/bLGB0MzGpJ

[Dana-Farber @DanaFarber]

We asked, and you answered.

Dana-Farber doctors are so many things — the best, life-changing, caring, superheroes, extraordinary, exceptional, unparalleled. Happy National Doctors' Day to our dedicated doctors. Thank you for all you do to reduce the burden of cancer for our patients and change lives everywhere. 💙

[Dana-Farber's Young-Onset Colorectal Cancer Center @DFarberYoungCRC]

For the month of March, the healing garden at @DanaFarber will be lit up blue every night in honor of colorectal cancer awareness month.💙 #ColorectalCancerAwarenessMonth #March #ColorectalCancer @KimmieNgMD

[Dana-Farber's Young-Onset Colorectal Cancer Center @DFarberYoungCRC]

Meet Gina Jacobson who will be our patient keynote speaker at our upcoming forum Saturday, March 7th! Gina is a stage 4 colon cancer survivor diagnosed at age 45 and we are so excited to have her share her story with us. It is not too late to register for this free event!

[Dana-Farber News @DanaFarberNews]

Donations of whole blood and platelets are urgently needed at @KraftBloodDonor due to the national collection shortage resulting from winter storm and flight disruptions. Make an appointment today to support patients of @DanaFarber and Brigham and Women's Hospital by calling 617-632-3206.

➡️ https://t.co/HhhsuLFLfS

[Dana-Farber @DanaFarber]

Our researchers are using novel spatial tools to learn how immune cells affect cancer. “I don’t think we appreciated how much the spatial dynamics of the immune system matter,” says @JudithAgudo1.

Learn more about what researchers are learning from this technology: https://t.co/zIihQu0xIV

[Dana-Farber @DanaFarber]

Just us, redefining the momentum of discovery & the future of cancer care 👀

[Andy Lane @lane_andy]

Busy #ASH25 for the Lane Lab. Hayden Bell on loss of the Y chromosome in AML, Qingyu Luo on KHSRP as a specific target in AML residual disease, Ran Xu on LiP-Seq for ultra-rare mantle cell lymphoma residual disease after CAR-T therapy, and me with phase 2 TAG-AZA-VEN for BPDCN:

[Susan Ehret @SusanDFCI]

OOO

[Dana-Farber @DanaFarber]

Congratulations to @DrTonyLetai on being named the new director of @theNCI. An internationally renowned researcher and oncologist, Letai has helped shape our understanding of cancer through his study of cell death. His appointment is a testament to our continuing commitment to innovation and collaboration.

Learn more: https://t.co/0dkpwnamrh

[Dana-Farber's Young-Onset Colorectal Cancer Center @DFarberYoungCRC]

Don't miss our own @KimmieNgMD on @NPR's It's Been A Minute podcast as she dives deep into young-onset colorectal cancer, why it isn't spoken about enough, and the importance of raising awareness and understanding one's family history. Listen here: https://t.co/Yutjvrg5ci

[Kimmie Ng, MD, MPH @KimmieNgMD]

I had such a great conversation about #YoungOnsetCancers today at @BostonGlobe’s #FutureofMed2025 Summit with @leung, Trisha Pasricha, and Shuji Ogino! Honored to have been invited to sit on this esteemed panel! @DanaFarber @DanaFarberNews @DFarberYoungCRC

[Dana-Farber News @DanaFarberNews]

Dr. Andy Wagner discusses advances and the ongoing research happening at @DanaFarber to better diagnose and treat cancer to improve outcomes for patients. Check out the story from @SpecNews1Worc that aired as part of a #StandUp2Cancer special.

➡️ https://t.co/IeCIGSqaVS